Biopsychosocial Health Disparities among Young Women Enrolled in Cardiac Rehabilitation

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 35, Issue 2, 2015, Pages 103-113

  Beckie, Theresa M ^a   Fletcher, Gerald ^b   Groer, Maureen W ^a   Kip, Kevin E ^a   Ji, Ming ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

cardiac rehabilitation; psychosocial; sex; women

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ANXIETY DISORDER; ARTICLE; BODY WEIGHT; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEALTH BEHAVIOR; HEALTH DISPARITY; HEART REHABILITATION; HEART VALVE REPLACEMENT; HOPE; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENTAL HEALTH; OBESITY; OPTIMISM; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SMOKING; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; STABLE ANGINA PECTORIS; STRESS; AGE; CARDIOVASCULAR DISEASES; HEALTH CARE DISPARITY; MIDDLE AGED; PSYCHOLOGY; WOMEN'S HEALTH; YOUNG ADULT;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; PSYCHOLOGY; WOMEN; WOMEN'S HEALTH; YOUNG ADULT;

EID: 85000201314     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000095     Document Type: Article

References (84)

1. National Center for Health Statistics. Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. Hyattsville, MD; 2012.
2. Bangalore S, Fonarow GC, Peterson ED, et al. Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med. 2012; 125 (10): 1000-1009.
3. Towfighi A, Markovic D, Ovbiagele B. National gender-specific trends in myocardial infarction hospitalization rates among patients aged 35 to 64 years. Am J Cardiol. 2011; 108 (8): 1102-1107.
4. Huffman MD, Lloyd-Jones DM, Ning H, et al. Quantifying options for reducing coronary heart disease mortality by 2020. Circulation. 2013; 127 (25): 2477-2484.
5. Dolor RJ, Melloni C, Chatterjee R, et al. Treatment Strategies for Women With Coronary Artery Disease. Comparative Effectiveness Review No. 66. Rockville, MD: Prepared by Duke Evidence-Based Practice Center; 2012.
6. Vaccarino V, Horwitz RI, Meehan TP, Petrillo MK, Radford MJ, Krumholz HM. Sex differences in mortality after myocardial infarction: evidence for a sex-age interaction. Arch Intern Med. 1998; 158 (18): 2054-2062.
7. Canto JG, Rogers WJ, Goldberg RJ, et al. Association of age and sex with myocardial infarction symptom presentation and inhospital mortality. JAMA. 2012; 307 (8): 813-822.
8. Champney KP, Frederick PD, Bueno H, et al. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart. 2009; 95 (11): 895-899.
9. Anderson ML, Peterson ED, Brennan JM, et al. Short-and longterm outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort. Circulation. 2012; 126 (18): 2190-2199.
10. Poon S, Goodman SG, Yan RT, et al. Bridging the gender gap: insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. Am Heart J. 2012; 163 (1): 66-73.
11. Wasfy JH, Rosenfield K, Zelevinsky K, et al. A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2013; 6 (4): 429-435.
12. Lichtman JH, Wang Y, Jones SB, et al. Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR ® . Am Heart J. 2014; 167 (3): 376-383.
13. Cannon CP, Brindis RG, Chaitman BR, et al. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. Circulation. 2013; 127 (9): 1052-1089.
14. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American heart association . Circulation. 2014; 129 (3): e28-e292.
15. Izadnegahdar M, Singer J, Lee MK, et al. Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years. J Womens Health (Larchmt). 2014; 23 (1): 10-17.
16. Lichtman JH, Lorenze NP, D'Onofrio G, et al. Variation in recovery: Role of gender on outcomes of young AMI patients (VIRGO) study design. Circ Cardiovasc Qual Outcomes. 2010; 3 (6): 684-693.
17. Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011; 124 (19): 2145-2154.
18. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007; 50 (22): 2128-2132.
19. Zhang Z, Fang J, Gillespie C, Wang G, Hong Y, Yoon PW. Agespecific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol. 2012; 109 (8): 1097-1103.
20. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123 (8): 933-944.
21. Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011; 7: CD001800.
22. Drozda J Jr, Messer JV, Spertus J, et al. ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Coronary Artery Disease and Hypertension: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2011; 124 (2): 248-270.
23. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011; 123 (11): 1243-1262.
24. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011; 124 (22): 2458-2473.
25. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 60 (24): e44-e164.
26. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127 (4): e362-425.
27. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012; 60 (7): 645-681.
28. Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2007; 115 (20): 2675-2682.
29. Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009; 54 (1): 25-33.
30. Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol. 2008; 51 (17): 1619-1631.
31. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006; 113 (19): 2363-2372.
32. Balady GJ, Ades PA, Bittner VA, et al. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American heart association. Circulation. 2011; 124 (25): 2951-2960.
33. Davies P, Taylor F, Beswick A, et al. Promoting patient uptake and adherence in cardiac rehabilitation. Cochrane Database Syst Rev. 2010; 7: CD007131.
34. Clark AM, King-Shier KM, Spaling MA, et al. Factors influencing participation in cardiac rehabilitation programmes after referral and initial attendance: qualitative systematic review and metasynthesis . Clin Rehabil. 2013; 27 (10): 948-959.
35. Parashar S, Spertus JA, Tang F, et al. Predictors of early and late enrollment in cardiac rehabilitation, among those referred, after acute myocardial infarction. Circulation. 2012; 126 (13): 1587-1595.
36. Beckie TM, Beckstead JW. Predicting cardiac rehabilitation attendance in a gender-tailored randomized clinical trial. J Cardiopulm Rehabi Prev. 2010; 30 (3): 147-156.
37. Daniels KM, Arena R, Lavie CJ, Forman DE. Cardiac rehabilitation for women across the lifespan. Am J Med. 2012; 125 (9): 937 e931-937.
38. Turk-Adawi KI, Oldridge NB, Tarima SS, Stason WB, Shepard DS. Cardiac rehabilitation patient and organizational factors: what keeps patients in programs ? J Am Heart Assoc. 2013; 2 (5): e000418.
39. Mochari-Greenberger H, Miller KL, Mosca L. Racial/ethnic and age differences in women's awareness of heart disease. J Womens Health (Larchmt). 2012; 21 (5): 476-480.
40. Mosca L, Hammond G, Mochari-Greenberger H, et al. Fifteenyear trends in awareness of heart disease in women: results of a 2012 American Heart Association National Survey. Circulation. 2013; 127 (11): 1254-1263.
41. Kling JM, Miller VM, Mankad R, et al. Go Red for Women cardiovascular health-screening evaluation: the dichotomy between awareness and perception of cardiovascular risk in the community. J Womens Health (Larchmt). 2013; 22 (3): 210-218.
42. Galbraith EM, Mehta PK, Veledar E, Vaccarino V, Wenger NK. Women and heart disease: knowledge, worry, and motivation. J Womens Health (Larchmt). 2011; 20 (10): 1529-1534.
43. Beckie TM. A behavior change intervention for women in cardiac rehabilitation. J Cardiovasc Nurs. 2006; 21 (2): 146-153.
44. Beckie TM, Beckstead JW. The effects of a cardiac rehabilitation program tailored for women on global quality of life: a randomized clinical trial. J Womens Health (Larchmt). 2010; 19 (11): 1977-1985.
45. Beckie TM, Beckstead JW. The effects of a cardiac rehabilitation program tailored for women on their perceptions of health: a randomized clinical trial. J Cardiopulm Rehabil Prev. 2011; 31 (1): 25-34.
46. Beckie TM, Beckstead JW, Schocken DD, Evans ME, Fletcher GF. The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: a randomized clinical trial. Int. J Nurs Stud. 2011; 48 (1): 3-12.
47. Beckie TM, Beckstead JW, Groer MW. The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. J Cardiovasc Nurs. 2010; 25 (1): 52-60.
48. Beckie TM, Groer MW, Beckstead JW. The relationship between polymorphisms on chromosome 9p21 and age of onset of coronary heart disease in black and white women. Genet Test Mol Biomarkers. 2011; 15 (6): 435-442.
49. Beckie TM, Mendonca MA, Fletcher GF, Schocken DD, Evans ME, Banks SM. Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial. J Cardiopulm Rehabil Prev. 2009; 29 (1): 13-21.
50. Beckie TM, Beckstead JW, Groer MW. The association between variants on chromosome 9p21 and inflammatory biomarkers in ethnically diverse women with coronary heart disease: a pilot study. Biol Res Nurs. 2011; 13 (3): 306-319.
51. Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36 Health Survey. Lincoln, RI: QualityMetric Incorporated; 2000.
52. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists; 1983.
53. Radloff L. The CES-D scale: a self-report depression scale for researching the general population. Appl Psychol Measures. 1977; 1: 385-401.
54. Cantril H. The Pattern of Human Concerns. NJ: Rutgers University Press; 1965.
55. Michalos A. Global Report on Student Well-being: Volume 1: Life Satisfaction and Happiness. NY: Springer-Verlag; 1991.
56. Vaglio J Jr, Conard M, Poston WS, et al. Testing the performance of the ENRICHD Social Support Instrument in cardiac patients. Health Qual Life Outcomes. 2004; 2: 24.
57. Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992; 17: 1251-1259.
58. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and selfesteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994; 67 (6): 1063-1078.
59. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on high blood pressure research. Circulation. 2005; 111 (5): 697-716.
60. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exerc. 1980; 12 (3): 175-181.
61. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2002; 106 (14): 1883-1892.
62. Myers J, Arena R, Franklin B, et al. Recommendations for clinical exercise laboratories: a scientific statement from the American Heart Association. Circulation. 2009; 119 (24): 3144-3161.
63. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. 8th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2010.
64. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999; 341 (4): 217-225.
65. Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med. 2009; 169 (19): 1767-1774.
66. Puymirat E, Simon T, Steg PG, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction . JAMA. 2012; 308 (10): 998-1006.
67. Robbins CL, Dietz PM, Cox S, Kuklina EV. Cholesterol screening for women: who is "at-risk"? J Womens Health (Larchmt). 2013; 22 (5): 404-411.
68. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011; 378 (9799): 1297-1305.
69. van Loon JE, de Maat MP, Deckers JW, van Domburg RT, Leebeek FW. Prognostic markers in young patients with premature coronary heart disease. Atherosclerosis. 2012; 224 (1): 213-217.
70. Reibis R, Treszl A, Wegscheider K, Bestehorn K, Karmann B, Voller H. Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients. Vasc Health Risk Manag. 2012; 8: 473-481.
71. Reese RL, Freedland KE, Steinmeyer BC, Rich MW, Rackley JW, Carney RM. Depression and rehospitalization following acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2011; 4 (6): 626-633.
72. Davidson KW, Burg MM, Kronish IM, et al. Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry. 2010; 67 (5): 480-488.
73. Parashar S, Rumsfeld JS, Reid KJ, et al. Impact of depression on sex differences in outcome after myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009; 2 (1): 33-40.
74. Smolderen KG, Spertus JA, Reid KJ, et al. The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009; 2 (4): 328-337.
75. Shah AJ, Veledar E, Hong Y, Bremner JD, Vaccarino V. Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. Arch Gen Psychiatry. 2011; 68 (11): 1135-1142.
76. Rutledge T, Linke SE, Johnson BD, et al. Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Psychosom Med. 2010; 72 (6): 549-555.
77. Doering LV, McKinley S, Riegel B, et al. Gender-specific characteristics of individuals with depressive symptoms and coronary heart disease. Heart Lung. 2011; 40 (3): e4-14.
78. Rutledge T, Vaccarino V, Johnson BD, et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Col Cardiol. 2009; 53 (2): 176-183.
79. Myers V, Gerber Y, Benyamini Y, Goldbourt U, Drory Y. Postmyocardial infarction depression: Increased hospital admissions and reduced adoption of secondary prevention measures. A longitudinal study. J Psychosom Res. 2012; 72 (1): 5-10.
80. Rutledge T, Redwine LS, Linke SE, Mills PJ. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med. 2013; 75 (4): 335-349.
81. Arnold SV, Smolderen KG, Buchanan DM, Li Y, Spertus JA. Perceived stress in myocardial infarction: long-term mortality and health status outcomes. J Am Coll Cardiol. 2012; 60 (18): 1756-1763.
82. Leifheit-Limson EC, Reid KJ, Kasl SV, et al. The role of social support in health status and depressive symptoms after acute myocardial infarction: evidence for a stronger relationship among women. Circ Cardiovasc Qual Outcomes. 2010; 3 (2): 143-150.
83. Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010; 72 (6): 563-569.
84. Chamberlain AM, Vickers KS, Colligan RC, Weston SA, Rummans TA, Roger VL. Associations of preexisting depression and anxiety with hospitalization in patients with cardiovascular disease. Mayo Clin Proc. 2011; 86 (11): 1056-1062.